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Introduction {#osp43-sec-0005}
============

The prevalence of disability increases with age and is accelerated in the presence of diabetes [1](#osp43-bib-0001){ref-type="ref"}, [2](#osp43-bib-0002){ref-type="ref"}. Physical disability contributes to loss of independence, premature mortality and increased healthcare spending [3](#osp43-bib-0003){ref-type="ref"}, [4](#osp43-bib-0004){ref-type="ref"} and is consistently predicted by poor performance on several objective measures of physical function and strength [5](#osp43-bib-0005){ref-type="ref"}, [6](#osp43-bib-0006){ref-type="ref"}, [7](#osp43-bib-0007){ref-type="ref"}. As older adults make up an increasingly larger proportion of the diabetic population [8](#osp43-bib-0008){ref-type="ref"}, identification and treatment of risk factors for diabetes‐related disability are emerging as a significant public health research priority.

Obesity is closely associated with diabetes and is a well‐characterized, modifiable predictor of functional decline in older adults [9](#osp43-bib-0009){ref-type="ref"}, [10](#osp43-bib-0010){ref-type="ref"}, [11](#osp43-bib-0011){ref-type="ref"}, [12](#osp43-bib-0012){ref-type="ref"}, [13](#osp43-bib-0013){ref-type="ref"}. Treatments for obesity, such as diet and exercise interventions, that result in significant weight loss frequently yield immediate improvement in risk factors for diabetes progression [14](#osp43-bib-0014){ref-type="ref"} and physical performance [15](#osp43-bib-0015){ref-type="ref"}, [16](#osp43-bib-0016){ref-type="ref"}, [17](#osp43-bib-0017){ref-type="ref"}. However, for most individuals, stable, long‐term, weight loss maintenance is unlikely [18](#osp43-bib-0018){ref-type="ref"}, [19](#osp43-bib-0019){ref-type="ref"}, [20](#osp43-bib-0020){ref-type="ref"}, and data assessing the impact of weight fluctuation following intentional weight loss on physical performance in older adults, particularly those at increased risk for disability, are limited.

Some insight into this question is provided from three prospective epidemiologic studies, with data suggesting weight loss and weight cycling are associated with increased risk of mobility disability in middle‐aged and older adults [21](#osp43-bib-0021){ref-type="ref"}, [22](#osp43-bib-0022){ref-type="ref"}, [23](#osp43-bib-0023){ref-type="ref"}. However, these studies did not assess objective measures of physical function and strength, and only one [23](#osp43-bib-0023){ref-type="ref"} controlled for self‐reported intentionality of weight change. To the best of our knowledge, the long‐term impact of body weight change following an intentional, structured weight loss programme on objective measures of physical performance in older adults with diabetes has yet to be assessed. Results are necessary to comprehensively evaluate the long‐term benefits and risks of intentional weight loss in this population.

The purpose of this study is to explore the associations of weight change following intentional weight loss (i.e. weight pattern classification of weight loss maintainers, continued losers, regainers or cyclers based on a ±5% annual change in weight) on objective measures of physical function and strength, including expanded physical performance battery (PPB) score, 20‐ and 400‐m walk tests, and grip and knee strength, measured in the Action for Health in Diabetes (Look AHEAD) Movement and Memory (M&M) ancillary study. We hypothesize that individuals who experience weight cycling or weight regain following intentional weight loss will perform worse on measures of physical function and strength compared with individuals who continue to lose weight or maintain their weight loss.

Methods and procedures {#osp43-sec-0006}
======================

Look AHEAD study design {#osp43-sec-0007}
-----------------------

The design and methods of the Look AHEAD trial have been published previously [24](#osp43-bib-0024){ref-type="ref"}. In brief, Look AHEAD recruited individuals with type 2 diabetes who were 45--76 years of age and had a body mass index (BMI) [\>]{.ul}25 kg/m^2^ ([\>]{.ul}27 kg/m^2^ in participants on insulin), glycosylated haemoglobin (HbA1c) \<11%, systolic blood pressure \<160 mmHg, diastolic blood pressure \<100 mmHg and triglycerides \<600 mg/dL. Participants were randomized to a usual care condition (i.e. diabetes support and education) or to an intensive lifestyle intervention (ILI), with a goal in the ILI arm of inducing a loss of 7% or more of initial weight and increasing physical activity to 175 min or more per week [25](#osp43-bib-0025){ref-type="ref"}.

The Look AHEAD M&M ancillary study enrolled Look AHEAD participants at four clinical centres to assess physical and cognitive function at either their year 8 or 9 Look AHEAD clinical examination. Only Look AHEAD participants who were currently active (i.e. had not been lost to follow‐up or refused further Look AHEAD activity) at the Baton Rouge, Denver, Memphis and Pittsburgh clinics and who provided separate informed consent were eligible to enrol. The Look AHEAD M&M protocol and consent forms were approved by local institutional review boards prior to use. Primary outcome papers, including recruitment and retention details, were published with modest treatment effects observed for physical, but not cognitive, function endpoints [26](#osp43-bib-0026){ref-type="ref"}, [27](#osp43-bib-0027){ref-type="ref"}.

Study population {#osp43-sec-0008}
----------------

Because this analysis examines the effect of changing weight dynamics following intentional weight loss on physical performance, only individuals in the ILI arm were included. A total of 2570 Look AHEAD participants were randomized to the ILI arm, of which 499 participated in the Look AHEAD M&M ancillary study and had a clinic visit during the year 8/9 exam. Ninety‐one percent of this subgroup lost at least 0.1% of their baseline weight at the year 1 visit and had at least two additional annual weights (*n* = 455). Participants lacking pertinent covariates \[*n* = 5; 3 missing diabetes duration and 2 missing Short Form‐36 Health Survey {SF‐36}\] were further excluded, yielding a final analysis sample of 450 participants (197 men and 253 women).

Weight pattern classifications {#osp43-sec-0009}
------------------------------

Certified clinic staff, masked to intervention assignment, collected annual measures of weight, using a Tanita BWB 800 digital scale (Tanita Corp., Arlington Heights, IL), throughout the Look AHEAD trial. Longitudinal measures of body weight were used to classify individuals into three weight pattern categories, (i) continued losers or maintainers, (ii) regainers and (iii) cyclers, utilizing definitions previously employed in the Cardiovascular Health Study [22](#osp43-bib-0022){ref-type="ref"}. Briefly, a 5% weight change from year to year was used to define weight patterns, as a change ≥5% is considered clinically significant [28](#osp43-bib-0028){ref-type="ref"}, and the participant year 1 (i.e. post‐intensive weight loss or post Phase I [25](#osp43-bib-0025){ref-type="ref"}) weight served as the referent point. Weight at follow‐up visits during years 2--8 were first compared with both the referent point and weight from previous year to categorize each follow‐up visit into one of the three weight pattern categories. Then, weight pattern category at each follow‐up visit was compared with other follow‐up visit categories to yield an overall weight pattern category across the 8‐year follow‐up period.

Participants were classified as 'maintainers' if their weight changed by \<5% from the prior year and from the year 1 weight. Participants were classified as 'regainers' if they gained ≥5% from the prior year and the year 1 weight and 'continued losers' if they lost ≥5% from the prior year and the year 1 weight. Once a participant was categorized as a regainer or continued loser, they remained in that group unless weight changed sufficiently in the opposite direction to qualify them as a 'cycler'. For example, if a participant lost ≥5% weight in comparison with year 1, yet gained in comparison with the previous year, they would be categorized as a cycler for that follow‐up year and would remain a cycler for the overall weight pattern category. Similarly, having a combination of 'loser' and 'gainer' across yearly categories would result in an overall cycler categorization. Due to the relatively small number of participants classified as either continued losers (*n* = 49) or maintainers (*n* = 35), these categories were combined for subsequent analyses.

Physical function and strength assessments {#osp43-sec-0010}
------------------------------------------

The Look AHEAD M&M study assessed objective measures of physical function and strength using certified staff who were masked to intervention assignment during a clinic exam at the eighth or ninth year of Look AHEAD follow‐up [27](#osp43-bib-0027){ref-type="ref"}. The expanded physical performance battery (expanded PPB; [5](#osp43-bib-0005){ref-type="ref"}, [29](#osp43-bib-0029){ref-type="ref"}) consists of standing balance tasks, time to complete five repeated chair stands and a 4‐m walk to assess usual gait speed. Performance on these tasks is converted to a continuous score, ranging from 0 to 3, with higher scores indicative of better performance (*n* = 445). Usual walking speed over 20 m and walking endurance over 400 m were also measured [30](#osp43-bib-0030){ref-type="ref"} (*n* = 430 and 413 for the 20‐ and 400‐m walk tests, respectively). Grip strength (kg) was measured twice in each hand using an isometric Hydraulic Hand Dynamometer (Jamar, Bolingbrook, IL). The maximum force from two trials for the stronger hand was used in the analyses (*n* = 425). Maximum knee extensor muscle strength (lb; one repetition maximum) was assessed on a Nautilus One™ Leg Extension machine (*n* = 328). The right leg was tested unless there was a contraindication (e.g. prior knee surgery). If participants experienced knee pain during the test and there were no contraindications to test the other leg, the other leg was tested.

Potential risk factors for physical limitations {#osp43-sec-0011}
-----------------------------------------------

All baseline physical performance risk factor measurements were obtained by certified staff. Self‐reported characteristics (i.e. age, gender, race, education and smoking status) and medical history were captured using standardized questionnaires. Participants brought current prescription medications to update medication records. Subscales of the SF‐36 were used as measures of self‐reported bodily pain and physical functioning status, with higher scores indicative of better functioning or well‐being [31](#osp43-bib-0031){ref-type="ref"}. Depressive symptoms were assessed using the Beck Depression Inventory (BDI). Total scores on the BDI range from 0 to 63, with higher scores indicating more symptoms of depression [32](#osp43-bib-0032){ref-type="ref"}.

Height was measured in duplicate using a stadiometer, and BMI was calculated as weight in kilograms divided by height in square meters. Blood specimens were collected after at least a 12‐h fast and were analysed by the Central Biochemistry Laboratory (Northwest Lipid Research Laboratories, University of Washington, Seattle, WA) using standardized laboratory procedures for measuring HbA1c. A maximal graded exercise test was administered at baseline, with results recorded as metabolic equivalents (METS). Lastly, total length of hospital stays prior to the ancillary visit was assessed based on participant medical records.

Statistical analysis {#osp43-sec-0012}
--------------------

Due to a significant association between gender and weight pattern classification, all results are presented stratified by gender and were initially analysed using descriptive statistics. Comparisons between groups were carried out using chi‐square tests for proportions and *t*‐tests or [anova]{.smallcaps} procedures for continuous variables. The Wilcoxon rank sum test was used for BDI due to non‐normality. Analysis of covariance models was used to compare all outcome measures. Three sets of models were fitted for each outcome measure: a minimal model including age, gender, race, education and clinic site as covariates (model 1), a further adjusted model that also included baseline insulin use, hypertension, cardiovascular disease (CVD) history, smoking status, BMI, HbA1c, self‐reported diabetes duration, baseline fitness (METS), SF‐36 physical functioning and pain subscales, and BDI score (\<11 or ≥11); interim hospitalizations (model 2); and a third model that also adjusted for year 1 weight change from baseline (model 3). Additional sensitivity analyses were performed, including (i) stratification of analyses by achievement of the study weight loss goal (≥7%) at year 1 and (ii) separation of the weight cyclers into single or multiple cycler categories resulting in a four‐category weight pattern variable. All analyses were performed in SAS 9.3 (Cary, NC), and a two‐sided *α* level of 0.05 was considered significant.

Results {#osp43-sec-0013}
=======

Participant characteristics {#osp43-sec-0014}
---------------------------

Average age of the study sample (*n* = 450) was 59.0 ± 6.9 years, 56% were women and 20% were African--American. Baseline BMI was 35.5 ± 5.9 kg/m^2^, and average percent weight loss at the year 1 visit was 10.2 ± 6.5%, with men reporting greater losses than women (−11.1 ± 6.1% vs. −9.5 ± 6.7%; *p* = 0.01). Compared with other ILI participants at the Look AHEAD M&M clinics (*n* = 221), participants included in our analyses were more likely to have a college or graduate education (*p* \< 0.01), not have had a hospital stay during follow‐up (*p* \< 0.01) and have lower baseline HbA1c (0.23%; *p* = 0.01).

Characteristics of men and women at baseline, by weight pattern category, are shown in Table [1](#osp43-tbl-0001){ref-type="table-wrap"}. Overall, the majority of participants were categorized as regainers (44%), followed by weight cyclers (38%) and then continued losers/maintainers (18%), with women more likely to be classified as weight cyclers and men more likely to be classified as regainers (*p* \< 0.01). No difference in weight pattern category was seen by age, education, diabetes duration and control, chronic disease (diabetes‐related variables, hypertension or CVD), depression, smoking status, fitness or self‐reported pain at baseline for either gender, although marginally significant group differences in baseline hypertension and depression, and total length of hospital stays prior to the ancillary visit were seen in men. Both men and women classified as regainers or weight cyclers were more likely to be White than continued loser/maintainers (who were more likely to be African--American/Black). Men classified as weight cyclers were also more likely to have a higher weight/BMI and worse self‐reported physical functioning at baseline than continued losers/maintainers or regainers.

###### 

Descriptive baseline characteristics by gender and weight cycling category

                                                                          Male            Female                                                                                                                   
  ----------------------------------------------------------------------- --------------- --------------- --------------- --------------- -------- --------------- --------------- --------------- --------------- --------
  Total                                                                   197             32              108             57                       253             48              90              115             
  Age (years)                                                             60.12 ± 6.64    60.72 ± 6.92    59.78 ± 6.69    60.44 ± 6.49      0.71   58.09 ± 6.96    58.50 ± 7.04    58.01 ± 6.82    57.98 ± 7.08      0.90
  \<60                                                                    97              17 (53.13)      53 (49.07)      27 (47.37)        0.87   150             26 (54.17)      55 (61.11)      69 (60.00)        0.72
  ≥60                                                                     100             15 (46.88)      55 (50.93)      30 (52.63)               103             22 (45.83)      35 (38.89)      46 (40.00)      
  Race                                                                                                                                     \<0.01                                                                    0.08
  African--American/Black                                                 21              8 (25.00)       9 (8.33)        4 (7.02)                 71              21 (43.75)      20 (22.22)      30 (26.09)      
  White                                                                   164             21 (65.63)      97 (89.81)      46 (80.70)               163             23 (47.92)      64 (71.11)      76 (66.09)      
  Other/mixed                                                             12              3 (9.38)        2 (1.85)        7 (12.28)                19              4 (8.33)        6 (6.67)        9 (7.83)        
  Education                                                                                                                                 0.46                                                                     0.52
  High school or less                                                     15              2 (6.25)        10 (9.26)       3 (5.26)                 54              12 (25.00)      15 (16.67)      27 (23.48)      
  Post high school                                                        67              8 (25.00)       41 (37.96)      18 (31.58)               104             22 (45.83)      38 (42.22)      44 (38.26)      
  College/graduate                                                        115             22 (68.75)      57 (52.78)      36 (63.16)               95              14 (29.17)      37 (41.11)      44 (38.26)      
  Body mass index (kg/m^2^)                                               34.55 ± 5.26    33.93 ± 6.20    33.63 ± 4.64    36.65 ± 5.30     \<0.01  36.19 ± 6.20    37.36 ± 6.33    35.39 ± 5.89    36.32 ± 6.35      0.20
  Weight (kg)                                                             108.6 ± 18.66   106.1 ± 21.97   106.2 ± 16.43   114.4 ± 19.68     0.02   96.39 ± 17.41   99.49 ± 17.14   94.11 ± 16.04   96.88 ± 18.44     0.21
  Year 1 percent weight change[\*\*\*](#osp43-note-0004){ref-type="fn"}   ‐11.1 ± 6.14    ‐6.92 ± 4.68    ‐13.6 ± 5.98    ‐8.57 ± 4.77     \<0.01  ‐9.52 ± 6.69    ‐5.58 ± 3.48    ‐10.9 ± 6.13    ‐10.1 ± 7.50     \<0.01
  HbA1c (%)                                                               7.15 ± 1.16     7.08 ± 0.81     7.08 ± 1.17     7.32 ± 1.31       0.42   7.17 ± 1.07     7.25 ± 1.10     7.08 ± 1.07     7.21 ± 1.05       0.60
  Any insulin use (% yes)                                                 30              5 (15.63)       16 (14.81)      9 (15.79)         0.98   43              13 (27.08)      15 (16.67)      15 (13.04)        0.09
  Diabetes duration (years)                                               6.92 ± 6.24     6.75 ± 3.60     6.66 ± 6.59     7.51 ± 6.77       0.70   5.64 ± 6.04     5.08 ± 5.45     5.92 ± 7.18     5.65 ± 5.28       0.74
  Hypertension (% yes)                                                    165             24 (75.00)      88 (81.48)      53 (92.98)        0.06   210             43 (89.58)      71 (78.89)      96 (83.48)        0.28
  Cardiovascular disease history (% yes)                                  42              9 (28.13)       21 (19.44)      12 (21.05)        0.57   28              8 (16.67)       6 (6.67)        14 (12.17)        0.18
  Beck Depression Inventory[\*\*\*\*](#osp43-note-0005){ref-type="fn"}    4.07 ± 3.88     4.22 ± 3.87     3.49 ± 3.27     5.07 ± 4.71       0.14   5.89 ± 4.86     7.13 ± 6.27     5.96 ± 4.45     5.33 ± 4.43       0.27
  \<11                                                                    182             28 (87.50)      104 (96.30)     50 (87.72)        0.07   219             38 (79.17)      80 (88.89)      101 (87.83)       0.24
  ≥11                                                                     15              7 (12.28)       4 (3.70)        4 (12.50)                34              10 (20.83)      10 (11.11)      14 (12.17)      
  Smoking status                                                                                                                            0.65                                                                     0.88
  Never                                                                   67              13 (40.63)      39 (36.11)      15 (26.32)               153             26 (54.17)      57 (63.33)      70 (60.87)      
  Former                                                                  122             18 (56.25)      65 (60.19)      39 (68.42)               88              19 (39.58)      29 (32.22)      40 (34.78)      
  Current                                                                 8               1 (3.13)        4 (3.70)        3 (5.26)                 12              3 (6.25)        4 (4.44)        5 (4.35)        
  Fitness (METs)                                                          8.27 ± 2.03     8.39 ± 2.14     8.48 ± 1.84     7.81 ± 2.25       0.12   6.76 ± 1.65     6.45 ± 1.42     6.84 ± 1.69     6.81 ± 1.71       0.36
  Short Form‐36 Health Survey                                                                                                                                                                                      
  Bodily pain                                                             51.28 ± 8.87    52.73 ± 8.65    51.57 ± 8.59    49.92 ± 9.47      0.32   49.70 ± 8.54    48.15 ± 9.38    50.17 ± 7.74    49.97 ± 8.77      0.38
  Physical functioning                                                    49.44 ± 7.22    50.32 ± 6.06    50.49 ± 6.80    46.95 ± 8.06     \<0.01  47.33 ± 8.26    45.85 ± 8.05    48.05 ± 7.98    47.39 ± 8.56      0.33
  Total length of hospital stays prior to ancillary visit (days)                                                                            0.07                                                                     0.71
  0                                                                       81              12 (37.50)      50 (46.30)      19 (33.33)               100             19 (39.58)      40 (44.44)      41 (35.65)      
  1--7                                                                    75              14 (43.75)      42 (38.89)      19 (33.33)               88              18 (37.50)      27 (30.00)      43 (37.39)      
  \>7                                                                     41              6 (18.75)       16 (14.81)      19 (33.33)               65              11 (22.92)      23 (25.56)      31 (26.96)      

Weight pattern categories defined based on ±5% change in annual weight.

Chi‐square for categorical variables and [anova]{.smallcaps} *F*‐test for continuous.

Compared with baseline.

*p*‐value is from Wilcoxon rank sum test.

HbA1c = glycosylated haemoglobin; METS = metabolic equivalents; SD, standard deviation.

Change in weight by weight pattern category {#osp43-sec-0015}
-------------------------------------------

Year 1 percent weight change differed among weight pattern categories for both genders. Interestingly, both men and women who achieved the 7% weight loss goal at year 1 had 2.91 (1.68--5.06) and 7.82 (4.38--13.96) times the odds of being classified as a cycler or regainer than a continued loser/maintainer, respectively, compared with participants who did not meet the 7% weight loss goal at year 1. By the year 8 visit, on average, regainers gained (mean ± SD) 9.6 ± 6.7 kg (10.3 ± 6.9 and 8.7 ± 6.3 kg for men and women, respectively), weight cyclers gained 1.4 ± 10.4 kg (1.2 ± 9.5 and 1.5 ± 10.9 kg for men and women, respectively) and continued losers/maintainers lost 4.9 ± 7.5 kg (−2.7 ± 3.9 and −6.3 ± 8.9 kg for men and women, respectively) from the year 1 visit weight (Figure [1](#osp43-fig-0001){ref-type="fig"}).

![Graphical depiction of weight loss trends for each weight pattern category for men (A) and women (B).](OSP4-1-12-g001){#osp43-fig-0001}

Associations between physical performance and weight pattern category {#osp43-sec-0016}
---------------------------------------------------------------------

Performance on physical function and strength tests at the year 8/9 visit, by weight pattern category and gender, is presented in Table [2](#osp43-tbl-0002){ref-type="table-wrap"}. Overall, mean gait speed was faster than 1.0 m/s for both the 20‐ and 400‐m walk. Expanded PPB score was 1.68 ± 0.40, and men had greater grip and knee strength than women. In unadjusted analyses, weight pattern category was found to be predictive of expanded PPB score, gait speed and grip strength in men. Weight cyclers consistently performed worse on select measures of physical performance and strength (compared with regainers for PPB and gait speed, and both losers/maintainers and regainers for grip strength; Table [2](#osp43-tbl-0002){ref-type="table-wrap"}). Conversely, in unadjusted analyses, weight pattern category did not appear to be predictive of follow‐up physical performance or strength in women.

###### 

Physical performance measures at Look AHEAD Y8/Y9 Memory and Movement ancillary visit by gender and weight cycling category

                                           Weight pattern category                                                  
  --------------------------------- ----- ------------------------- --------------- --------------- --------------- --------
  Expanded PPB score (range 0--3)                                                                                   
  Male                               195         1.73 ± 0.40          1.69 ± 0.43     1.81 ± 0.33     1.61 ± 0.46     0.02
  Female                             250         1.64 ± 0.40          1.67 ± 0.35     1.64 ± 0.43     1.63 ± 0.39     0.94
  20‐m gait speed (m/s)                                                                                             
  Male                               189         1.21 ± 0.20          1.22 ± 0.22     1.25 ± 0.18     1.15 ± 0.23     0.02
  Female                             241         1.12 ± 0.22          1.14 ± 0.20     1.14 ± 0.25     1.10 ± 0.21     0.63
  400‐m gait speed (m/s)                                                                                            
  Male                               185         1.12 ± 0.19          1.13 ± 0.19     1.15 ± 0.17     1.06 ± 0.21     0.04
  Female                             228         1.03 ± 0.17          1.02 ± 0.15     1.04 ± 0.19     1.03 ± 0.17     0.93
  Grip strength (kg)                                                                                                
  Male                               189        39.08 ± 8.72         42.10 ± 8.82    39.82 ± 7.91    35.99 ± 9.34    \<0.01
  Female                             236        24.80 ± 5.96         24.02 ± 5.58    25.61 ± 6.40    24.54 ± 5.78     0.94
  Knee extensor strength (lb)                                                                                       
  Male                               164        70.40 ± 22.88        63.78 ± 22.42   73.69 ± 21.60   67.07 ± 25.13    0.08
  Female                             164        32.79 ± 12.54        29.19 ± 10.38   33.63 ± 13.62   33.62 ± 12.36    0.21

From unadjusted [anova]{.smallcaps} *F*‐test.

PPB = physical performance battery.

Table [3](#osp43-tbl-0003){ref-type="table-wrap"} presents adjusted [anova]{.smallcaps} results of physical performance measures by weight cycling category for men and women, respectively. Interestingly, in minimally adjusted models (model 1), weight cycling was associated with a lower score on the expanded PPB, slower walking speed and weaker grip strength in men. After further covariate adjustment (model 2), however, only grip strength in men was associated with weight pattern category (*p* \< 0.01). Specifically, weight cyclers had lower grip strength at the year 8/9 visit when compared with weight regainers or continued losers/maintainers (30.12 ± 2.21 vs. 34.46 ± 2.04 and 37.39 ± 2.26 kg, respectively). Additional adjustment for year 1 percent weight change did not significantly alter effect size estimates; however, a trend was observed for weaker knee extensor strength in the continued losers/maintainer category compared with regainer or cycler categories (model 3; *p* = 0.08). When absolute knee extensor strength was divided by weight (to yield relative knee strength), this association was further attenuated.

###### 

Adjusted [anova]{.smallcaps} results of testing physical performance measures with weight cycling category from gender stratified analyses

                                     Weight pattern category                                
  --------------------------------- ------------------------- -------------- -------------- --------
  Expanded PPB score (range 0--3)                                                           
  Male                                                                                      
  Model 1                                  1.69 ± 0.07         1.78 ± 0.06    1.59 ± 0.06    \<0.01
  Model 2                                  1.73 ± 0.09         1.80 ± 0.08    1.71 ± 0.08     0.26
  Model 3                                  1.74 ± 0.09         1.80 ± 0.08    1.72 ± 0.09     0.44
  Female                                                                                    
  Model 1                                  1.69 ± 0.06         1.62 ± 0.05    1.61 ± 0.04     0.52
  Model 2                                  1.57 ± 0.07         1.45 ± 0.07    1.46 ± −0.07    0.13
  Model 3                                  1.63 ± 0.07         1.46 ± 0.07    1.48 ± 0.07     0.02
  20‐m gait speed (m/s)                                                                     
  Male                                                                                      
  Model 1                                  1.21 ± 0.04         1.26 ± 0.03    1.16 ± 0.04    \<0.01
  Model 2                                  1.20 ± 0.05         1.23 ± 0.05    1.19 ± 0.05     0.41
  Model 3                                  1.23 ± 0.05         1.23 ± 0.05    1.21 ± 0.05     0.87
  Female                                                                                    
  Model 1                                  1.16 ± 0.03         1.14 ± 0.03    1.11 ± 0.03     0.31
  Model 2                                  1.14 ± 0.04         1.09 ± 0.04    1.07 ± 0.04     0.11
  Model 3                                  1.17 ± 0.04         1.10 ± 0.04    1.08 ± 0.04     0.03
  400‐m gait speed (m/s)                                                                    
  Male                                                                                      
  Model 1                                  1.13 ± 0.04         1.17 ± 0.03    1.08 ± 0.04    \<0.01
  Model 2                                  1.11 ± 0.05         1.14 ± 0.04    1.10 ± 0.05     0.37
  Model 3                                  1.13 ± 0.05         1.14 ± 0.04    1.12 ± 0.05     0.80
  Female                                                                                    
  Model 1                                  1.03 ± 0.03         1.03 ± 0.02    1.03 ± 0.02     0.98
  Model 2                                  1.00 ± 0.03         0.97 ± 0.03    0.98 ± 0.03     0.52
  Model 3                                  1.02 ± 0.03         0.97 ± 0.03    0.98 ± 0.03     0.27
  Grip strength (kg)                                                                        
  Male                                                                                      
  Model 1                                 41.43 ± 1.74         37.86 ± 1.37   34.03 ± 1.46   \<0.01
  Model 2                                 38.07 ± 2.19         34.36 ± 2.05   30.75 ± 2.16   \<0.01
  Model 3                                 37.39 ± 2.26         34.46 ± 2.04   30.12 ± 2.21   \<0.01
  Female                                                                                    
  Model 1                                 22.69 ± 0.93         24.55 ± 0.78   23.34 ± 0.68    0.17
  Model 2                                 22.67 ± 1.25         24.45 ± 1.26   23.27 ± 1.18    0.21
  Model 3                                 22.98 ± 1.30         24.49 ± 1.27   23.36 ± 1.19    0.30
  Knee extensor strength (lb)                                                               
  Male                                                                                      
  Model 1                                 63.47 ± 4.79         72.54 ± 3.80   67.99 ± 4.30    0.13
  Model 2                                 65.94 ± 6.00         75.86 ± 5.48   73.51 ± 5.94    0.11
  Model 3                                 64.71 ± 6.18         76.02 ± 5.49   72.22 ± 6.15    0.08
  Female                                                                                    
  Model 1                                 28.23 ± 2.49         34.07 ± 2.11   33.51 ± 1.90    0.08
  Model 2                                 27.53 ± 3.59         33.69 ± 3.42   34.00 ± 3.35    0.05
  Model 3                                 27.99 ± 3.70         33.72 ± 3.43   34.08 ± 3.36    0.08

Model 1 = age, gender, race, education and clinic. Model 2 = Model 1 + baseline insulin use, hypertension, cardiovascular disease history, smoking status, body mass index, glycosylated haemoglobin %, self‐reported diabetes duration, baseline fitness, Short Form‐36 Health Survey physical functioning and pain subscales, Beck Depression Inventory (\<11 or ≥11) and interim hospitalizations. Model 3 = Model 2 + year 1 weight change from baseline.

PPB = physical performance battery.

A nearly opposite pattern was observed in women, with associations produced in models 1 and 2 suggestive of no effect of weight pattern classification on follow‐up physical performance. However, after further adjustment for year 1 weight change from baseline (model 3), weight regain and cycling were associated with lower PPB score (*p* = 0.02) and slower 20‐m gait speed (*p* = 0.03) compared with a pattern of weight maintenance or continued weight loss. Interestingly, for both genders, the association between slower gait speed and lower grip strength estimates did not differ by bouts of weight cycling (all pairwise comparisons between one weight cycle and multiple cycles, *p* \> 0.10).

Lastly, because year 1 percent weight change appeared to be such an influential covariate to model results, analytic models 1 and 2 were stratified by achievement of the study‐wide weight loss goal at year 1 (7% of baseline weight). Stratification did not affect results in women; however, the association between weight cycling and low grip strength remained only for men who lost ≥7% of their baseline weight at year 1 (*p* = 0.04). Additionally, in minimally adjusted models (model 1), cycling men who lost ≥7% of baseline weight at year 1 also had significantly lower expanded PPB scores (*p* = 0.01), and slower 20‐m (*p* = 0.03) and 400‐m (*p* = 0.02) gait speed than loser/maintainer or regainer groups, although these findings were attenuated to non‐significance after adjustment for additional covariates (data not shown).

Discussion {#osp43-sec-0017}
==========

This study is the first to assess the effect of weight pattern dynamics following intentional weight loss on objective measures of physical function and strength in a well‐functioning sample of older adults with diabetes. Differential classification of weight pattern status following weight loss by gender was observed, with women more likely to be classified as weight cyclers and continued losers/maintainers than men over the 7 years of follow‐up. Women categorized as weight cyclers and regainers presented with worse expanded PPB score and slower 20‐m gait speed at the year 8/9 clinic visit compared with women categorized as continued losers/maintainers. Similarly, men categorized as weight cyclers presented with weaker follow‐up grip strength compared with men in the regainer or continued loser/maintainer categories. Importantly, effect size differences observed between weight pattern categories (i.e. expanded PPB score, 0.16; gait speed, 0.08 m/s; grip strength, 6 kg) are considered clinically meaningful [33](#osp43-bib-0033){ref-type="ref"}, [34](#osp43-bib-0034){ref-type="ref"}. Thus, clinicians promoting weight loss in this population should emphasize stable weight loss maintenance for prolonged functional independence.

Results presented here contribute to a growing body of literature assessing the effect of weight change on physical performance in at‐risk populations for future disability. Our findings support and extend reports generated from other large, observational studies, linking weight gain [35](#osp43-bib-0035){ref-type="ref"}, [36](#osp43-bib-0036){ref-type="ref"} and variability [22](#osp43-bib-0022){ref-type="ref"}, [23](#osp43-bib-0023){ref-type="ref"} in middle‐to‐late life with lower self‐reported functional status, particularly in women, by providing confirmatory data using objective measures of physical performance. Long‐term results (8--9 years) presented here are also in agreement with an emerging body of shorter‐term (12--18 months) randomized controlled trial data, suggesting that lifestyle‐based interventions resulting in intentional weight loss of 7--10% are associated with improved physical function and strength in older adults [16](#osp43-bib-0016){ref-type="ref"}, [17](#osp43-bib-0017){ref-type="ref"}, [37](#osp43-bib-0037){ref-type="ref"}. It is interesting to note that the year 1 weight change was strongly related to weight pattern classification over the next 7 years \[with achievement of the 7% weight loss goal at year 1 associated with increased odds of weight regain {women only} and cycling {men and women}\] and may also exacerbate associations between body weight dynamics and physical performance.

Gender differences reported here are intriguing and may be explained by weight change associated changes in body composition. Longitudinal studies of body composition in older adults show a tendency towards a loss of lean and a gain of fat mass over time, which may be exaggerated during a cycle of weight regain [38](#osp43-bib-0038){ref-type="ref"}, particularly in older women [39](#osp43-bib-0039){ref-type="ref"}. Total body fat mass is more strongly associated with physical performance in women (compared with men) [40](#osp43-bib-0040){ref-type="ref"}, and a relative increase in fat mass in women classified as regainers or weight cyclers in the current study may explain their worse follow‐up expanded PPB score and 20‐m gait speed. This line of thinking is only speculative, however, and should be the focus of future work as we do not specifically examine associations between change in body composition and physical performance. The negative association between cycling and grip strength in men is in general agreement with other findings linking weight fluctuation to increased risk of physical disability [22](#osp43-bib-0022){ref-type="ref"}, [23](#osp43-bib-0023){ref-type="ref"}; however, it is curious that this association was only observed in one outcome measure (of five). Overall, men are less likely to present with disability than women [41](#osp43-bib-0041){ref-type="ref"}, and perhaps their physical performance is also less likely to be affected by changing weight dynamics.

Strengths of this study include the use of measured weights to assess changing weight dynamics following an intentional weight loss and adjustment for multiple covariates, which may confound our observed relationship between weight pattern classification and physical performance. This study is not without limitations, however. Because physical performance measures were only assessed at the year 8/9 visit, changes over time could not be assessed. A general limitation in this field of research is the lack of an operational definition for weight cycling. Although our choice of 5% weight change was used previously in a similarly designed study [22](#osp43-bib-0022){ref-type="ref"} and is consistent with clinically meaningful weight change [28](#osp43-bib-0028){ref-type="ref"}, conclusions may differ by weight pattern definitions used. Varying definitions also make true cross‐study comparisons difficult; studies testing similar hypotheses varied in weight change thresholds used to construct their weight pattern categories from a relative 5% weight change [21](#osp43-bib-0021){ref-type="ref"}, [22](#osp43-bib-0022){ref-type="ref"}, to an absolute weight change of 5--30 lb [23](#osp43-bib-0023){ref-type="ref"}, [36](#osp43-bib-0036){ref-type="ref"}, to absolute change over time [35](#osp43-bib-0035){ref-type="ref"}, and no other study assigned weight pattern categories following an intentional weight loss intervention (as was carried out in the present analysis). Lastly, extrapolation of results should be limited to similar populations, particularly with regard to age and disease status.

In sum, data presented here suggest that weight regain and cycling following intentional weight loss in middle‐aged and older adults with diabetes contribute to worse physical function in women and grip strength in men. Importantly, for weight cyclers, this was true despite a relatively small increase in absolute weight from the year 1 visit. Given the known immediate benefit of weight loss on physical performance measures, adoption of effective weight loss maintenance strategies may have the potential to maintain and preserve independent living in overweight and obese, middle‐aged and older adults with diabetes.
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[University of Colorado Health Sciences Center]{.ul} James O. Hill, PhD^1^; Marsha Miller, MS, RD^2^; Brent Van Dorsten, PhD^3^; Judith Regensteiner, PhD^3^; Ligia Coelho, BS; Paulette Cohrs, RN, BSN; Susan Green; April Hamilton, BS, CCRC; Jere Hamilton, BA; Eugene Leshchinskiy; Lindsey Munkwitz, BS; Loretta Rome, TRS; Terra Worley, BA; Kirstie Craul, RD, CDE; Sheila Smith, BS

[The University of Tennessee Health Science Center]{.ul} *University of Tennessee East.* Karen C. Johnson, MD, MPH^1^; Carolyn Gresham, RN^2^; Stephanie Connelly, MD, MPH^3^; Amy Brewer, RD, MS; Mace Coday, PhD; Lisa Jones, RN; Lynne Lichtermann, RN, BSN; Shirley Vosburg, RD, MPH; and J. Lee Taylor, MEd, MBA. *University of Tennessee Downtown.* Abbas E. Kitabchi, PhD, MD^1^; Ebenezer Nyenwe, MD^3^; Helen Lambeth, RN, BSN^2^; Amy Brewer, MS, RD,LDN; Debra Clark, LPN; Andrea Crisler, MT; Debra Force, MS, RD, LDN; Donna Green, RN; Robert Kores, PhD

[University of Pittsburgh]{.ul} John M. Jakicic, PhD^1^, David E. Kelley, MD^1^; Jacqueline Wesche‐Thobaben, RN, BSN, CDE^2^; Lewis H. Kuller, MD, DrPH^3^; Andrea Kriska, PhD^3^; Amy D. Otto, PhD, RD, LDN^3^, Lin Ewing, PhD, RN^3^, Mary Korytkowski, MD^3^, Daniel Edmundowicz, MD^3^; Monica E. Yamamoto, DrPH, RD, FADA ^3^; Rebecca Danchenko, BS; Barbara Elnyczky; David O. Garcia, MS; George A. Grove, MS; Patricia H. Harper, MS, RD, LDN; Susan Harrier, BS; Nicole L. Helbling, MS, RN; Diane Ives, MPH; Juliet Mancino, MS, RD, CDE, LDN; Anne Mathews, PhD, RD, LDN; Tracey Y. Murray, BS; Joan R. Ritchea; Susan Urda, BS, CTR; Donna L. Wolf, PhD

**[Coordinating Center]{.ul}**

[Wake Forest University]{.ul} Stephen B. Kritchevsky, PhD^1^; Denise K. Houston, PhD^3^; Jeff D. Williamson, MD^3^; Stephen R. Rapp, PhD^3^; Mark A. Espeland, PhD^3^; Xiaoyna (Iris) Leng, MD, PhD^3^; Gary Miller, PhD^3^; Kristen M. Beavers, PhD^3^, Amelia Hodges, BS, CCRP^2^; Michelle Gordon, MS; Jennifer Walker; Tara Beckner; Jason Griffin, BS; Lea Harvin, BS; Kathy Lane, BS; Rebecca H. Neiberg, MS

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
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^3^Co‐investigator

All other Look AHEAD staffs are listed alphabetically by site.

Funding and Support {#osp43-sec-0021}
===================

This ancillary study is supported by the National Institute on Aging, National Institutes of Health, Department of Health and Human Services, R01 AG03308701. The Action for Health in Diabetes is supported through the following cooperative agreements from the National Institutes of Health: DK57136, DK57149, DK56990, DK57177, DK57171, DK57151, DK57182, DK57131, DK57002, DK57078, DK57154, DK57178, DK57219, DK57008, DK57135 and DK56992. The following federal agencies have contributed support: National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Nursing Research; National Center on Minority Health and Health Disparities; Office of Research on Women\'s Health; the Centers for Disease Control and Prevention; and the Department of Veterans Affairs. This research was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The Indian Health Service (IHS) provided personnel, medical oversight and use of facilities. The opinions expressed in this paper are those of the authors and do not necessarily reflect the views of the IHS or other funding sources.

Additional support was received from the University of Colorado Health Sciences Center General Clinical Research Center (M01RR00051) and Clinical Nutrition Research Unit (P30 DK48520); the University of Tennessee at Memphis General Clinical Research Center (M01RR0021140); and the University of Pittsburgh General Clinical Research Center (GCRC) (M01RR000056), the Clinical Translational Research Center (CTRC) funded by the Clinical & Translational Science Award (UL1 RR 024153) and NIH grant (DK 046204); and the Frederic C. Bartter General Clinical Research Center (M01RR01346).

The following organizations have committed to make major contributions to Look AHEAD: FedEx Corporation; Health Management Resources; LifeScan, Inc., a Johnson & Johnson Company; OPTIFAST® of Nestle HealthCare Nutrition, Inc.; Hoffmann‐La Roche Inc.; Abbott Nutrition; and Slim‐Fast Brand of Unilever North America.

GAB, JOH, DKH, JMJ, KCJ and SBK designed the research; RHN and KMB analysed data; KMB, GAB, JOH, DKH, JMJ, KCJ, RHN and SBK contributed to the writing of the article; KMB had primary responsibility for final content. All authors read and approved the final manuscript.

Additionally, we gratefully acknowledge all Look AHEAD M&M study team members and funding sources:
